(Q34990615)

5 August 2017

1 reference

title

Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity (English)

1 reference

5 August 2017

1 reference

1 reference

Peter O Kwiterovich

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

American Journal of Cardiology

5 August 2017

published in

1 reference

5 August 2017

volume

90

1 reference

5 August 2017

issue

8A

1 reference

5 August 2017

page(s)

30i-47i

1 reference

Coronary risk prediction in adults (the Framingham Heart Study)

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Approach to lipoprotein management in 2001 National Cholesterol Guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

The effect of dietary fat, antioxidants, and pro-oxidants on blood lipids, lipoproteins, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

State-of-the-art update and review: clinical trials of lipid-lowering agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Inflammation and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Novel clinical markers of vascular wall inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Lipoprotein abnormalities related to women's health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Measurement issues related to lipoprotein heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Dietary and genetic effects on low-density lipoprotein heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

The role of small, dense low density lipoprotein (LDL): a new look

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Novel genes for familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

How, when, and why to use apolipoprotein B in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

High-density lipoproteins and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Familial lipoprotein disorders in patients with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

LDL physical and chemical properties in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

A proposal to redefine familial combined hyperlipidaemia - Third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the Scientific Sessions of the European Society for Clinical Investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

LDL particle size distribution. Results from the Framingham Offspring Study

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

7 January 2021

inferred from DOI database lookup

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Role of insulin resistance in human disease (syndrome X): an expanded definition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Pathophysiology of insulin resistance in human disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Relationship of insulin sensitivity and ApoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Of mice and men (and women) and the acylation-stimulating protein pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Insulin resistance and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Relation of plasma triglyceride and apoB levels to insulin-mediated suppression of nonesterified fatty acids. Possible explanation for sex differences in lipoprotein pattern.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Abnormal protein tyrosine phosphorylation in fibroblasts from hyperapobetalipoproteinemia subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Impaired chylomicron remnant clearance in familial combined hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Postprandial hypertriglyceridemia(s): time to enlarge our pathophysiologic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Etiologic heterogeneity of hyperapobetalipoproteinemia (hyperapoB). Results from segregation analysis in families with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

High plasma insulin and triglyceride concentrations and blood pressure in offspring of people with impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Insulin insensitivity in offspring of parents with type 2 diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Evidence for joint genetic control of insulin sensitivity and systolic blood pressure in hispanic families with a hypertensive proband

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Fetal nutrition and adult disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Evidence for genetic factors explaining the birth weight-blood pressure relation. Analysis in twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Linkage analysis of low-density lipoprotein subclass phenotypes and the apolipoprotein B gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, ApoB, and triglyceride levels in young african american men: results from the coronary artery risk development in young adults (CARDIA) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Large buoyant LDL-like particles in hepatic lipase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Apolipoprotein B-100 Hopkins (Arginine4019 [unk] Tryptophan)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Replication of Linkage of Familial Combined Hyperlipidemia to Chromosome 1q With Additional Heterogeneous Effect of Apolipoprotein A-I/C-III/A-IV Locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Mapping a gene for combined hyperlipidaemia in a mutant mouse strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Positional cloning of the combined hyperlipidemia gene Hyplip1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Locus for elevated apolipoprotein B levels on chromosome 1p31 in families with familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Soluble receptors for tumor necrosis factor-alpha (TNF-R p55 and TNF-R p75) in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Insulin effect during embryogenesis determines fetal growth: a possible molecular link between birth weight and susceptibility to type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Premature atherosclerosis associated with monogenic insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

IRS proteins and beta-cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Insulin inhibits transcription of IRS-2 gene in rat liver through an insulin response element (IRE) that resembles IREs of other insulin-repressed genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

The atherogenic lipoprotein phenotype and vascular endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Low density lipoprotein subfractions increase thromboxane formation in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Low density lipoprotein subfractions and [Ca2+]i in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Low-density lipoprotein size, pravastatin treatment, and coronary events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Mechanism of action of niacin on lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Beneficial effect of gemfibrozil on the chemical composition and oxidative susceptibility of low density lipoprotein: a randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

Hyperapobetalipoproteinemia. Plasma lipoprotein responses to oral fat load.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

7 January 2021

inferred from DOI database lookup

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902749-2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0002-9149(02)02749-2

1 reference

release_k4f5g6zh6jbznla2avyqe33e4i

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k4f5g6zh6jbznla2avyqe33e4i

24 November 2022

mapped directly with Wikidata item

1 reference